Nanocarriers for Targeted Drug Delivery in Cancer Therapy: Innovations and Challenges Busayo Olamide Tomoh

Stephen Vure Gbaraba; Ashiata Yetunde Mustapha; Akachukwu Obianuju Mbata; Adelaide Yeboah Forkuo   Corresponding Author Email:

doi:10.56201/ijmepr.v9.no1.2025.pg152.184

Nanocarriers for Targeted Drug Delivery in Cancer Therapy: Innovations and Challenges Busayo Olamide Tomoh

Stephen Vure Gbaraba , Ashiata Yetunde Mustapha , Akachukwu Obianuju Mbata , and Adelaide Yeboah Forkuo Corresponding Author Email:

Abstract

Nanocarriers have revolutionized the field of targeted drug delivery in cancer therapy, offering enhanced specificity and reduced side effects compared to traditional treatments. These nanoscale delivery systems, including liposomes, dendrimers, and polymeric nanoparticles, are engineered to deliver chemotherapeutic agents directly to cancer cells, thus sparing healthy tissues. The ability of nanocarriers to enhance the pharmacokinetics and biodistribution of anticancer drugs has led to significant improvements in therapeutic outcomes and patient quality of life. Innovations in nanocarrier technology have focused on improving targeting efficiency and drug release mechanisms. Active targeting strategies, such as ligand-receptor interactions, enable nanocarriers to selectively bind to cancer cell surface markers, enhancing drug accumulation in tumor tissues. Additionally, stimuli-responsive nanocarriers, which release their payload in response to specific internal or external triggers (e.g., pH, temperature, or light), provide controlled and on-demand drug release, minimizing systemic toxicity and improving therapeutic efficacy. Recent advancements include the development of multifunctional nanocarriers capable of simultaneous imaging and therapy (theranostics), which allow for real-time monitoring of drug delivery and treatment response. These innovations are paving the way for personalized cancer therapy, where treatment regimens can be tailored to the individual patient's tumor profile and disease progression. Despite the promising potential, several challenges remain in the clinical translation of nanocarrier-based therapies. Manufacturing complexities, scalability issues, and stringent regulatory requirements pose significant barriers to commercialization. Additionally, biological challenges such as immune system recognition and clearance, potential toxicity, and the heterogeneity of tumor environments complicate the effect

Keywords

Nanocarriers; Drug Delivery; Cancer Therapy; Innovations; Challenges

References

Abatan, A., Adeyinka, M. A., Sodiya, E. O., Jacks, B. S., Ugwuanyi, E. D., Daraojimba, O. H., & Lottu, O. A. (2024). The role of IT in sustainable environmental management: A global perspective review. Adeusi, K. B., Adegbola, A. E., Amajuoyi, P., Adegbola, M. D., & Benjamin, L. B. (2024). The potential of IoT to transform supply chain management through enhanced connectivity and real-time data. Adeusi, K. B., Amajuoyi, P., & Benjami, L. B. (2024). Utilizing machine learning to predict employee turnover in high-stress sectors. International Journal of Management & Entrepreneurship Research, 6(5), 1702-1732. Ajegbile, M. D., Olaboye, J. A., Maha, C. C., & Tamunobarafiri, G. (2024). Integrating business analytics in healthcare: Enhancing patient outcomes through data-driven decision making. Ajegbile, M. D., Olaboye, J. A., Maha, C. C., Igwama, G. T., & Abdul, S. (2024). The role of data- driven initiatives in enhancing healthcare delivery and patient retention. World Journal of Biology Pharmacy and Health Sciences, 19(1), 234-242. Ajirotutu, R.O., Matthew, B., Garba, P., Johnson, S.O. (2024a). AI-driven risk mitigation: Transforming project management in construction and infrastructure development. World Journal of Advanced Engineering Technology and Sciences, 2024,13(02), 611-623. https://doi.org/10.30574/wjaets.2024.13.2.0628 Ajirotutu, R.O., Matthew, B., Garba, P., Johnson, S.O. (2024b). Advancing lean construction through Artificial Intelligence: Enhancing efficiency and sustainability in project management. World Journal of Advanced Engineering Technology and Sciences, 2024, 13(02), 496-509. https://doi.org/10.30574/wjaets.2024.13.2.0623 Akinbolaji, T.J., Nzeako, G., Akokodaripon, D., Aderoju, A.V., Shittu, R.A. (2023). Enhancing fault tolerance and scalability in multi-region Kafka clusters for high-demand cloud platforms. World Journal of Advanced Research and Reviews 18 (1), 1248-1262. https://doi.org/10.30574/wjarr.2023.18.1.0629 Akinbolaji, T.J., Nzeako, G., Akokodaripon, D., Aderoju, A.V. (2024). Proactive monitoring and security in cloud infrastructure: Leveraging tools like Prometheus, Grafana, and HashiCorp Vault for robust DevOps practices. World Journal of Advanced Engineering Technology and Sciences 13 (2), 74-89. https://doi.org/10.30574/wjaets.2024.13.2.0543 Akinsola, A., & Ejiofor, O. (2024). Securing the Future of Healthcare: Building A Resilient Defense System for Patient Data Protection. Available at SSRN 4902351. Akinsola, A., Njoku, T. K., Ejiofor, O., & Akinde, A. (2024). Enhancing Data Privacy In Wireless Sensor Networks: Investigating Techniques And Protocols To Protect Privacy Of Data Transmitted Over Wireless Sensor Networks In Critical Applications Of Healthcare And National Security. International Journal of Network Security & Its Applications. Akpukorji, I.S., Nzeako, G., Akinsanya, M.O., Popoola, O.A., Chukwurah, E.G., Okeke, C.D. (2024). Theoretical frameworks for regulatory compliance in Fintech innovation: A International Journal of Medical Evaluation and Physical

Nanocarriers for Targeted Drug Delivery in Cancer Therapy: Innovations and Challenges Busayo Olamide Tomoh

Abstract

Keywords

References

More Articles from INTERNATIONAL JOURNAL OF MEDICAL EVALUATION AND PHYSICAL REPORT